Emm, a biowearable tech startup based in Bristol, has raised $9m (£6.8m) in a seed funding round to bring its “smart menstrual cup” product to market.
Described by the firm as the first product of its kind, Emm is developing a sanitary product connected to an app that can help users track key metrics and receive actionable insights related to their menstrual health.
The wearable device measures flow volume and tracks “key cycle metrics” including duration, frequency and regularity to inform user health insights.
“Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies,” said Jenny Button, founder and chief executive of Emm.
“We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing.”
The funding round was led by Lunar Ventures and included additional participation from the Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures as well as angels including Wayve co-founder Amar Shah.
“We’re proud to back Jenny and the Emm team as they build the foundational technology to transform women’s health and drive measurable impact in chronic diseases,” said Lunar Ventures partner Mick Halsband.
“At Lunar, we invest in founders tackling complex engineering challenges across data, materials, and biological systems, and Emm exemplifies this with its world-class hardware and high-fidelity data. Their world-first platform has the potential to redefine standards of care and data quality in menstrual health and beyond.”
